adagrasib,Pembrolizumab
mirati,merck
['nsclc', 'impower,10', 'sclc', 'ca,022,i', 'ca,022,1', 'adagrasib', 'impower,30', 'atezo', 'krystal-1', 'impower010', 'thoracic', 'pembro', 'porter', 'award', 'lba4', 'sotorasib', 'lung', 'krystal-7', 'camrelizumab', 'valent ,(-prevalent)', 'valent ,(-prevalent),(-equivalent),(-bivalent)']
#esmoimmuno22:positive preliminary results for combination therapy with adagrasib in kras g12c-mutated #nsclc 
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.